Concepedia

Jeanne Allinne

JA

Statistics

Publications

4

Citations

702

H-Index

4

Active since

2019

Affiliations

Regeneron (United States)(Current)

Lund University

Jeanne Allinne is an author at Regeneron (United States) specializing in allergy, inflammation, and inflammatory cell responses.

Publications per year

2019–2025

4

Publications

4

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Audrey Le Floc’h, Jeanne Allinne, Kirsten Nagashima et al. · Allergy · 2019 · 490 citations · Full text

, , +17

IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation

Jeanne Allinne, George Scott, Wei Keat Lim et al. · Journal of Allergy and Clinical Immunology · 2019 · 114 citations · Full text

, , +17

IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline

George Scott, Seblewongel Asrat, Jeanne Allinne et al. · Cytokine · 2022 · 88 citations · Full text

, , +17

The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma

Seblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan et al. · Science Translational Medicine · 2025 · 10 citations

, , +17

1–4 of 4